Investigating how a specific receptor affects inflammation in brain cells related to Parkinson's Disease
Sigma-1 Receptor as a modulator of Astrocyte pro-inflammatory activities in Parkinson's Disease
This study is looking at how a specific brain cell receptor affects inflammation in the brain for people with Parkinson's Disease, hoping to find new ways to reduce inflammation and improve symptoms.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-10823507 on NIH RePORTER |
What this research studies
This research aims to understand how the sigma-1 receptor influences the inflammatory activities of astrocytes, a type of brain cell, in the context of Parkinson's Disease (PD). By studying the interactions between astrocytes and other cells in the central nervous system, the researchers hope to uncover the mechanisms that drive neuroinflammation and neurodegeneration in PD. The approach involves using animal models to simulate PD and examining how blocking certain pathways can reduce inflammation and potentially improve symptoms. This research could lead to new therapeutic targets for treating PD.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with Parkinson's Disease who are experiencing motor deficits and neuroinflammation.
Not a fit: Patients with Parkinson's Disease who are in advanced stages or have significant comorbidities may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that reduce inflammation in the brain and slow the progression of Parkinson's Disease.
How similar studies have performed: Previous research has shown that targeting astrocyte inflammatory responses can improve outcomes in models of neurological diseases, suggesting that this approach may be promising.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Piester, Gavin Edward — University of Rochester
- Study coordinator: Piester, Gavin Edward
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.